These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?]. Calvo Romero JM. Rev Clin Esp; 2011 Mar; 211(3):142-6. PubMed ID: 21371701 [Abstract] [Full Text] [Related]
9. Public health. Change of heart. Taylor J. Health Serv J; 2012 Jul 26; 122(6315):19-20. PubMed ID: 23155563 [No Abstract] [Full Text] [Related]
13. Dabigatran in atrial fibrillation: incremental benefit over a time horizon of 5 or 10 years. Messori A, Fadda V, Maratea D, Trippoli S. J Cardiovasc Med (Hagerstown); 2013 Sep 26; 14(9):683-5. PubMed ID: 23032961 [No Abstract] [Full Text] [Related]
14. Is it time to abandon warfarin and embrace oral direct thrombin inhibitors to prevent stroke in patients with atrial fibrillation? Rahme RJ, Bernstein R, Batjer HH, Bendok BR. Neurosurgery; 2011 Feb 26; 68(2):N16-7. PubMed ID: 21654569 [No Abstract] [Full Text] [Related]